1.
Jørgensen CLT, Nielsen TO, Bjerre KD, Liu S, Wallden B, Balslev E, et al. PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients. AO [Internet]. 2014 Jun. 1 [cited 2026 May 18];53(6):776-87. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27112